1. Mancini M, Contaldo F, Lewis B. Medical Complications of Obesity. London: Academic Press; 1979. 2. Sims A. Are there persons who are obese, but metabolically healthy? Metabolism 2001;50:1499–1504. 3. Brochu M, Tchernof A, Dionne IJ, et al. What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women? J Clin Endocrinol Metab 2001;86:1020–5. 5. Hauner H. Secretory factors from human adipose tissue and their functional role. Proc Nutr Soc 2005;64:163–9. 6. Montani JP, Carroll JF, Dwyer TM, et al. Ectopic fat storage in heart, blood vessels and kidneys in the pathogenesis of cardiovascular diseases. Int J Obes Relat Metab Disord 2004 Dec;28(Suppl 4):S58–65. 7. Cottam DR, Matter SG, Barinas Mitchell E, et al. The chronic inflammatory hypothesis for the morbidity associated with morbid obesity: implications and effects of weight loss. Obes Surg 2004;14:589–600. 8. Fontana L, Eagon JC, Trujllo ME, et al. Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabetes 2007;56(4): 1010–3. 9. De Lorenzo A, Del Gobbo V, Premrov M.G, et al. Normal weight obese sindrome: early inflammation. Am J Clin Nutr 2007;85:40–5. 11. Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukine-6, and risk of developing type 2 diabetes. JAMA 2001;286:327–34. 12. Cote M, Mauriege P, Bergeron J, et al. Adiponectinemia in visceral obesity : impact on glucose tolerance and plasma lipoprotein and lipid levels in men. J Clin Endocrinol Metab 2005;90:1434–9. 13. Troiano RP, Frongillo EA Jr, Sobal J, et al. The relationship between body weight and mortality: a quantitative analysis of combined information from existing studies. Int J Obes 1996;20:62–75. 14. Flegal KM, Graubard BI, Williamson DF, et al. Excess death associated with underweight, overweight and obesity. JAMA 2005;293:1861–7. 15. Peeters A, Barendergt JJ, Willenkens F, et al. Obesity in adulthooh and its consequences for life expectancy: a life-table analysis. Ann Intern Med 2003;138:28–32. 16. Haslam DW, James WPT. Obesity. Lancet 2005;366: 1197–209. 17. Allison DB, Fontaine KR, Manson SE, et al. Annual death attributable to obesity in United States. JAMA 1999;282:1530–8. 19. Harris ML, Flegal KM, Cowie LL, et al. Prevalence of Diabetes, impaired fasting glucose, and impaired glucose tolerance in US adults: the Third National Health and Nutrition Examination Survey 1988–94. Diabetes Care 1998;21:518–24. 20. Colditz GA, Willet WC, Rotnitky A, et al. Weight gain as a risk factor for clinical diabetes in women. Ann Inter Med 1995;122:481–6. 21. Despres JP. The insulin resistance-dyslipidemic syndrome of visceral obesity: effect on patient’s risk. Obesity Rev 1998;6(1):8S–17S. 22. Hoene M, Weigert C. The role of interleukin-6 in insulinresistance, body fat distribution and energy balance. Obesity Rev 2008;9:20–9. 23. World Cancer Research Fund and American Institute for Cancer Research, Food, Nutrition, Physical Activity and the Prevention of Cancer: a global prospective. Washington, DC: AICR; 2007. 24. Renehan AG, Tyson M, Egger M, et al. Body mass index and incidence of cancer: a systematic review and metaanalysis of prospective observational studies. Lancet 2008;371:569–78. 25. Carmichall AR. Obesity and prognosis of breast cancer. Obesity Rev 2006;7:333–40.